|
1
|
Bray F, Laversanne M, Sung H, Ferlay J,
Siegel RL, Soerjomataram I and Jemal A: Global cancer statistics
2022: GLOBOCAN estimates of incidence and mortality worldwide for
36 cancers in 185 countries. CA Cancer J Clin. 74:229–263. 2024.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Teng Y, Xia C, Cao M, Yang F, Yan X, He S,
Cao M, Zhang S, Li Q, Tan N, et al: Esophageal cancer global burden
profiles, trends, and contributors. Cancer Biol Med. 21:656–666.
2024.PubMed/NCBI
|
|
3
|
Prabhu A, Obi KO and Rubenstein JH: The
synergistic effects of alcohol and tobacco consumption on the risk
of esophageal squamous cell carcinoma: A meta-analysis. Am J
Gastroenterol. 109:822–827. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Islami F, Ren JS, Taylor PR and Kamangar
F: Pickled vegetables and the risk of oesophageal cancer: A
meta-analysis. Br J Cancer. 101:641–1647. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Li B, Jiang G, Zhang G, Xue Q, Zhang H,
Wang C and Zhao T: Intake of vegetables and fruit and risk of
esophageal adenocarcinoma: A meta-analysis of observational
studies. Eur J Nutr. 53:1511–1521. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wong MCS, Deng Y, Huang J, Bai Y, Wang
HHX, Yuan J, Zhang L, Yip HC and Chiu PWY: Performance of screening
tests for esophageal squamous cell carcinoma: A systematic review
and meta-analysis. Gastrointest Endosc. 96:197–207.e34. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Min Q, Zhang M, Lin D, Zhang W, Li X, Zhao
L, Teng H, He T, Sun W, Fan J, et al: Genomic characterization and
risk stratification of esophageal squamous dysplasia. Med Rev.
4:244–256. 2024. View Article : Google Scholar
|
|
8
|
Sasaki F, Kanmura S, Oda K, Maeda H,
Kabayama M, Iwaya H, Komaki Y, Arima S, Tanoue S, Hashimoto S, et
al: Acetaldehyde breath test as a cancer risk marker in patients
with esophageal and hypopharyngeal squamous cell carcinoma. PLoS
One. 16:e02514572021. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Li K, Lin Y, Zhou Y, Xiong X, Wang L, Li
J, Zhou F, Guo Y, Chen S, Chen Y, et al: Salivary extracellular
MicroRNAs for early detection and prognostication of esophageal
cancer: A clinical study. Gastroenterology. 165:932–945.e9. 2023.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wang X, Yu N, Cheng G, Zhang T, Wang J,
Deng L, Li J, Zhao X, Xu Y, Yang P, et al: Prognostic value of
circulating tumour DNA during post-radiotherapy surveillance in
locally advanced esophageal squamous cell carcinoma. Clin Transl
Med. 12:e11162022. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Su M, Xiao Y, Ma J, Cao D, Zhou Y, Wang H,
Liao Q and Wang W: Long non-coding RNAs in esophageal cancer:
Molecular mechanisms, functions, and potential applications. J
Hematol Oncol. 11:1182018. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yan Q, Wong W, Gong L, Yang J, Liang D,
Chin KY, Dai S and Wang J: Roles of long non-coding RNAs in
esophageal cell squamous carcinoma (Review). Int J Mol Med.
54:722024. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Li H, Jia J, Yang L, Chu J, Sheng J, Wang
C, Meng W, Jia Z, Yin H, Wan J and He F: LncRNA MIR205HG drives
esophageal squamous cell carcinoma progression by regulating
miR-214/SOX4 axis. Onco Targets Ther. 13:13097–13109. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Jia J, Li H, Chu J, Sheng J, Wang C, Jia
Z, Meng W, Yin H, Wa J and He F: LncRNA FAM83A-AS1 promotes ESCC
progression by regulating miR-214/CDC25B axis. J Cancer.
12:1200–1211. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhao Y, Zhang Q, Liu H, Wang N, Zhang X
and Yang S: lncRNA PART1, manipulated by transcriptional factor
FOXP2, suppresses proliferation and invasion in ESCC by regulating
the miR-18a-5p/SOX6 signaling axis. Oncol Rep. 45:1118–1132. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Li Z, Qin X, Bian W, Li Y, Shan B, Yao Z
and Li S: Exosomal lncRNA ZFAS1 regulates esophageal squamous cell
carcinoma cell proliferation, invasion, migration and apoptosis via
microRNA-124/STAT3 axis. J Exp Clin Cancer Res. 38:4772019.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wang L, Ren X, Ma X, Yin L, Niu X and Xing
S: LncRNA OIP5-AS1 promotes the development of esophageal squamous
cell carcinoma by binding to miR-1297. Panminerva Med. 64:589–590.
2022. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lin P, Li Q, Lv X, Qu J, Wang D, Li A and
Jiang G: HMGA1 promotes the development of esophageal squamous cell
carcinoma by mediating miR-671-5p/lncRNA DLEU1. Panminerva Med.
65:264–266. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Tang J, Xu H, Liu Q, Zheng J, Pan C, Li Z,
Wen W, Wang J, Zhu Q, Wang Z and Chen L: LncRNA LOC146880 promotes
esophageal squamous cell carcinoma progression via
miR-328-5p/FSCN1/MAPK axis. Aging (Albany NY). 13:14198–14218.
2021. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Xu ML, Liu TC, Dong FX, Meng LX, Ling AX
and Liu S: Exosomal lncRNA LINC01711 facilitates metastasis of
esophageal squamous cell carcinoma via the miR-326/FSCN1 axis.
Aging (Albany NY). 13:19776–19788. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wang Y, Zhang W, Liu W, Huang L, Wang Y,
Li D, Wang G, Zhao Z, Chi X, Xue Y, et al: Long noncoding RNA
VESTAR regulates lymphangiogenesis and lymph node metastasis of
esophageal squamous cell carcinoma by enhancing VEGFC mRNA
stability. Cancer Res. 81:3187–3199. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Xu ML, Liu TC, Dong FX, Meng LX, Ling AX
and Liu S: BBOX1-AS1 activates hedgehog signaling pathway to
facilitate the proliferation and stemness of esophageal squamous
cell carcinoma cells via miR-506-5p/EIF5A/PTCH1 axis. Curr Mol
Pharmacol. 16:894–904. 2023.PubMed/NCBI
|
|
23
|
Zhang Y, Liu D, Guo D, Lin W, Lu W, Hu L,
Chen S and Chen C: CPSF3 regulates alternative polyadenylation of
CNIH2 to promote esophageal squamous cell carcinoma progression.
Cancer Lett. 593:2169252024. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Cheng W, Shi X, Lin M, Yao Q, Ma J and Li
J: LncRNA MAGI2-AS3 overexpression sensitizes esophageal cancer
cells to irradiation through Down-regulation of HOXB7 via EZH2.
Front Cell Dev Biol. 8:5528222020. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Liu S, Li X, Xie Q, Zhang S, Liang X, Li S
and Zhang P: Identification of a lncRNA/circRNA-miRNA-mRNA network
in Nasopharyngeal Carcinoma by deep sequencing and bioinformatics
analysis. J Cancer. 15:1916–1928. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wang Z, Huang YF, Yu L and Jiao Y:
sh-HNF1A-AS1 reduces the epithelial-mesenchymal transition and
stemness of esophageal cancer cells. Neoplasma. 69:560–570. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Chen L, Lu J, Li X, Wang X, Qiao R, Guo W
and Ren Q: LncRNA KTN1-AS1 facilitates esophageal squamous cell
carcinoma progression via miR-885-5p/STRN3 axis. Genes Genomics.
46:241–252. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Li P, Ding H, Han S, Ding S and Yang Y:
Long noncoding RNA LINC00858 aggravates the progression of
esophageal squamous cell carcinoma via regulating the
miR-425-5p/ABL2 axis. Heliyon. 10:e273372024. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wu D, He X, Wang W, Hu X, Wang K and Wang
M: Long noncoding RNA SNHG12 induces proliferation, migration,
epithelial-mesenchymal transition, and stemness of esophageal
squamous cell carcinoma cells via post-transcriptional regulation
of BMI1 and CTNNB1. Mol Oncol. 14:2332–2351. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Li S, Lv C, Li J, Xie T, Liu X, Zheng Z,
Qin Z, Hui X and Yu Y: LncRNA LINC00473 promoted colorectal cancer
cell proliferation and invasion by targeting miR-195 expression. Am
J Transl Res. 13:6066–6075. 2021.PubMed/NCBI
|
|
31
|
Song B, Wei F, Peng J, Wei X, Liu M, Nie
Z, Ma Y and Peng T: Icariin regulates EMT and stem Cell-like
character in breast cancer through modulating lncRNA
NEAT1/TGFβ/SMAD2 signaling pathway. Biol Pharm Bull. 47:399–410.
2024. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Huang H, Huang F, Liang X, Fu Y, Cheng Z,
Huang Y, Chen Z, Duan Y and Chen Y: Afatinib reverses EMT via
inhibiting CD44-Stat3 axis to promote radiosensitivity in
nasopharyngeal carcinoma. Pharmaceuticals (Basel). 16:372022.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wu Y, Hu L, Liang Y, Li J, Wang K, Chen X,
Meng H, Guan X, Yang K and Bai Y: Up-regulation of lncRNA CASC9
promotes esophageal squamous cell carcinoma growth by negatively
regulating PDCD4 expression through EZH2. Mol Cancer. 16:1502017.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Cui Y, Zhang C, Ma S, Li Z, Wang W, Li Y,
Ma Y, Fang J, Wang Y, Cao W and Guan F: RNA m6A demethylase
FTO-mediated epigenetic up-regulation of LINC00022 promotes
tumorigenesis in esophageal squamous cell carcinoma. J Exp Clin
Cancer Res. 40:2942021. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zhang S, Liang Y, Wu Y, Chen X, Wang K, Li
J, Guan X, Xiong G, Yang K, Bai Y, et al: Upregulation of a novel
lncRNA LINC01980 promotes tumor growth of esophageal squamous cell
carcinoma. Biochem Biophys Res Commun. 513:73–80. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Wang M, Wang L, He X, Zhang J, Zhu Z,
Zhang M and Li X: lncRNA CCAT2 promotes radiotherapy resistance for
human esophageal carcinoma cells via the miR-145/p70S6K1 and p53
pathway. Int J Oncol. 56:327–336. 2020.PubMed/NCBI
|
|
37
|
Wu Q, Zhang H, Yang D, Min Q, Wang Y,
Zhang W and Zhan Q: The m6A-induced lncRNA CASC8 promotes
proliferation and chemoresistance via upregulation of hnRNPL in
esophageal squamous cell carcinoma. Int J Biol Sci. 18:4824–4836.
2022. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Zhang M, Wang Z, Wu Y, Chen M, Li J and
Liu G: Hypoxia-induced factor-1α promotes radioresistance of
esophageal cancer cells by transcriptionally activating LINC01116
and suppressing miR-3612 under hypoxia. J Biochem Mol Toxicol.
38:e235512024. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Zhang S, Zhong J, Guo D, Zhang S, Huang G,
Chen Y, Xu C, Chen W, Zhang Q, Zhao C, et al: MIAT shuttled by
tumor-secreted exosomes promotes paclitaxel resistance in
esophageal cancer cells by activating the TAF1/SREBF1 axis. J
Biochem Mol Toxicol. 37:e233802023. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Cao Z, Zhu J, Wang Z, Peng Y and Zeng L:
Comprehensive pan-cancer analysis reveals ENC1 as a promising
prognostic biomarker for tumor microenvironment and therapeutic
responses. Sci Rep. 14:253312024. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Lu JT, Yan ZY, Xu TX, Zhao F, Liu L, Li F
and Guo W: Reciprocal regulation of LINC00941 and SOX2 promotes
progression of esophageal squamous cell carcinoma. Cell Death Dis.
14:722023. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Li Q, Zhang Z, Jiang H, Hou J, Chai Y, Nan
H, Li F and Wang L: DLEU1 promotes cell survival by preventing
DYNLL1 degradation in esophageal squamous cell carcinoma. J Transl
Med. 20:2452022. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Huang J, Li J, Li Y, Lu Z, Che Y, Mao S,
Lei Y, Zang R, Zheng S, Liu C, et al: Interferon-inducible lncRNA
IRF1-AS represses esophageal squamous cell carcinoma by promoting
interferon response. Cancer Lett. 459:86–99. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Qian FC, Zhou LW, Li YY, Yu ZM, Li LD,
Wang YZ, Xu MC, Wang QY and Li CQ: SEanalysis 2.0: A comprehensive
Super-enhancer regulatory network analysis tool for human and
mouse. Nucleic Acids Res. 51:W520–W527. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Saville L, Wu L, Habtewold J, Cheng Y,
Gollen B, Mitchell L, Stuart-Edwards M, Haight T, Mohajerani M and
Zovoilis A: NERD-seq: A novel approach of Nanopore direct RNA
sequencing that expands representation of Non-coding RNAs. Genome
Biol. 25:2332024. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Liu Z, Gao L, Cheng L, Lv G, Sun B, Wang G
and Tang Q: The roles of N6-methyladenosine and its target
regulatory noncoding RNAs in tumors: Classification, mechanisms,
and potential therapeutic implications. Exp Mol Med. 55:487–501.
2023. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Plath K, Fang J, Mlynarczyk-Evans SK, Cao
R, Worringer KA, Wang H, de la Cruz CC, Otte AP, Panning B and
Zhang Y: Role of histone H3 lysine 27 methylation in X
inactivation. Science. 300:131–135. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Guttman M, Amit I, Garber M, French C, Lin
MF, Feldser D, Huarte M, Zuk O, Carey BW, Cassady JP, et al:
Chromatin signature reveals over a thousand highly conserved large
non-coding RNAs in mammals. Nature. 458:223–227. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Rinn JL, Kertesz M, Wang JK, Squazzo SL,
Xu X, Brugmann SA, Goodnough LH, Helms JA, Farnham PJ, Segal E and
Chang HY: Functional demarcation of active and silent chromatin
domains in human HOX loci by noncoding RNAs. Cell. 129:1311–1323.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Rinn JL and Chang HY: Genome regulation by
long noncoding RNAs. Annu Rev Biochem. 81:145–166. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Huarte M: The emerging role of lncRNAs in
cancer. Nat Med. 21:1253–1261. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Schmitt AM and Chang HY: Long Noncoding
RNAs in cancer pathways. Cancer Cell. 29:452–463. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Bhan A and Mandal SS: Long noncoding RNAs:
Emerging stars in gene regulation, epigenetics and human disease.
ChemMedChem. 9:1932–1956. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Yates AD, Achuthan P, Akanni W, Allen J,
Allen J, Alvarez-Jarreta J, Amode MR, Armean IM, Azov AG, Bennett
R, et al: Ensembl 2020. Nucleic Acids Res. 48:D682–D688.
2020.PubMed/NCBI
|
|
55
|
Mattick JS and Makunin IV: Non-coding RNA.
Hum Mol Genet. 15:R17–R29. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Katayama S, Tomaru Y, Kasukawa T, Waki K,
Nakanishi M, Nakamura M, Nishida H, Yap CC, Suzuki M, Kawai J, et
al: Antisense transcription in the mammalian transcriptome.
Science. 309:1564–1566. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Pelechano V and Steinmetz LM: Gene
regulation by antisense transcription. Nat Rev Genet. 14:880–893.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Ma L, Bajic VB and Zhang Z: On the
classification of long non-coding RNAs. RNA Biol. 10:925–934. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Quinn JJ and Chang HY: Unique features of
long non-coding RNA biogenesis and function. Nat Rev Genet.
17:47–62. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Cheng S, Jia Y, Wu J, Li J and Cao Y:
Helicobacter pylori infection induces gastric cancer cell
malignancy by targeting HOXA-AS2/miR-509-3p/MMD2 axis. Genes
Genomics. 46:647–657. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Yan S, Teng L, Du J, Ji L, Xu P, Zhao W
and Tao W: Long non-coding RNA DANCR aggravates breast cancer
through the miR-34c/E2F1 feedback loop. Mol Med Rep. 29:932024.
View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Wang C, Chen R, Zhu X, Zhang X and Lian N:
Long noncoding RNA small nucleolar RNA host gene 5 facilitates
neuropathic pain in spinal nerve injury by promoting SCN9A
expression via CDK9. Hum Cell. 37:451–464. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Geisler S and Coller J: RNA in unexpected
places: Long non-coding RNA functions in diverse cellular contexts.
Nat Rev Mol Cell Biol. 14:699–712. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Gudenas BL and Wang L: Prediction of
LncRNA subcellular localization with deep learning from sequence
features. Sci Rep. 8:163852018. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Gozzetti A and Le Beau MM: Fluorescence in
situ hybridization: Uses and limitations. Semin Hematol.
37:320–333. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Keene JD, Komisarow JM and Friedersdorf
MB: RIP-Chip: The isolation and identification of mRNAs, microRNAs
and protein components of ribonucleoprotein complexes from cell
extracts. Nat Protoc. 1:302–307. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Wang Z, Gerstein M and Snyder M: RNA-Seq:
A revolutionary tool for transcriptomics. Nat Rev Genet. 10:57–63.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Macosko EZ, Basu A, Satija R, Nemesh J,
Shekhar K, Goldman M, Tirosh I, Bialas AR, Kamitaki N, Martersteck
EM, et al: Highly parallel Genome-wide expression profiling of
individual cells using nanoliter droplets. Cell. 161:1202–1214.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Shaffer SM, Dunagin MC, Torborg SR, Torre
EA, Emert B, Krepler C, Beqiri M, Sproesser K, Brafford PA, Xiao M,
et al: Rare cell variability and drug-induced reprogramming as a
mode of cancer drug resistance. Nature. 546:431–435. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Hezroni H, Koppstein D, Schwartz MG,
Avrutin A, Bartel DP and Ulitsky I: Principles of long noncoding
RNA evolution derived from direct comparison of transcriptomes in
17 species. Cell Rep. 11:1110–1122. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Necsulea A, Soumillon M, Warnefors M,
Liechti A, Daish T, Zeller U, Baker JC, Grützner F and Kaessmann H:
The evolution of lncRNA repertoires and expression patterns in
tetrapods. Nature. 505:635–640. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Pang KC, Frith MC and Mattick JS: Rapid
evolution of noncoding RNAs: Lack of conservation does not mean
lack of function. Trends Genet. 22:1–5. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Carninci P, Kasukawa T, Katayama S, Gough
J, Frith MC, Maeda N, Oyama R, Ravasi T, Lenhard B, Wells C, et al:
The transcriptional landscape of the mammalian genome. Science.
309:1559–1563. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Derrien T, Johnson R, Bussotti G, Tanzer
A, Djebali S, Tilgner H, Guernec G, Martin D, Merkel A, Knowles DG,
et al: The GENCODE v7 catalog of human long noncoding RNAs:
Analysis of their gene structure, evolution, and expression. Genome
Res. 22:1775–1789. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Tong YS, Wang XW, Zhou XL, Liu ZH, Yang
TX, Shi WH, Xie HW, Lv J, Wu QQ and Cao XF: Identification of the
long non-coding RNA POU3F3 in plasma as a novel biomarker for
diagnosis of esophageal squamous cell carcinoma. Mol Cancer.
14:32015. View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Wang W, He X, Zheng Z, Ma X, Hu X, Wu D
and Wang M: Serum HOTAIR as a novel diagnostic biomarker for
esophageal squamous cell carcinoma. Mol Cancer. 16:752017.
View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Wang Y, Pang D and Zhang X: The function
of lncRNA LINC00997 as a diagnostic marker in the progression of
esophageal squamous cell carcinoma. Ann Clin Lab Sci. 53:230–237.
2023.PubMed/NCBI
|
|
78
|
Xie K, Zheng C, Gu W, Jiang Z, Luo C, Luo
J, Diao Y, Wang G, Cong Z, Yao X, et al: A RASSF8-AS1 based
exosomal lncRNAs panel used for diagnostic and prognostic
biomarkers for esophageal squamous cell carcinoma. Thorac Cancer.
13:3341–3352. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Yan Y, Li S, Wang S, Rubegni P, Tognetti
L, Zhang J and Yan L: Long noncoding RNA HAND2-AS1 inhibits cancer
cell proliferation, migration, and invasion in esophagus squamous
cell carcinoma by regulating microRNA-21. J Cell Biochem.
120:9564–9571. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Zhihua Z, Weiwei W, Lihua N, Jianying Z
and Jiang G: p53-induced long non-coding RNA PGM5-AS1 inhibits the
progression of esophageal squamous cell carcinoma through
regulating miR-466/PTEN axis. IUBMB Life. 71:1492–1502. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Zhou M, Bao S, Gong T, Wang Q, Sun J, Li
J, Lu M, Sun W, Su J, Chen H and Liu Z: The transcriptional
landscape and diagnostic potential of long non-coding RNAs in
esophageal squamous cell carcinoma. Nat Commun. 14:37992023.
View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Liu Y, Li T, Peng C, Mao Q, Shen B, Shi M,
Lu H, Xiao T, Yang A and Cheng C: Knockdown of long noncoding RNA
LINC00240 inhibits esophageal cancer progression by regulating
miR-26a-5p. Contrast Media Mol Imaging. 2022:10716272022.
View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Luo D, Huang Z, Lv H, Wang Y, Sun W and
Sun X: Up-regulation of MicroRNA-21 indicates poor prognosis and
promotes cell proliferation in esophageal squamous cell carcinoma
via upregulation of lncRNA SNHG1. Cancer Manag Res. 12:1–14. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Ma L, Yan W, Sun X and Chen P: Chen, long
noncoding RNA VPS9D1-AS1 promotes esophageal squamous cell
carcinoma progression via the Wnt/β-catenin signaling pathway. J
Cancer. 12:6894–6904. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Sun K, Zhao X, Wan J, Yang L, Chu J, Dong
S, Yin H, Ming L and He F: The diagnostic value of long non-coding
RNA MIR31HG and its role in esophageal squamous cell carcinoma.
Life Sci. 202:124–130. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Shi T, Gao G and Cao Y: Long noncoding
RNAs as novel biomarkers have a promising future in cancer
diagnostics. Dis Markers. 2016:90851952016. View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Shi K, Liu T, Fu H, Li W and Zheng X:
Zheng, Genome-wide analysis of lncRNA stability in human. PLoS
Comput Biol. 17:e10089182021. View Article : Google Scholar : PubMed/NCBI
|
|
88
|
Sole C, Arnaiz E, Manterola L, Otaegui D
and Lawrie CH: The circulating transcriptome as a source of cancer
liquid biopsy biomarkers. Semin Cancer Biol. 58:100–108. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
89
|
Lo YM: Circulating nucleic acids in plasma
and serum: An overview. Ann N Y Acad Sci. 945:1–7. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
90
|
Qi P, Zhou XY and Du X: Circulating long
non-coding RNAs in cancer: Current status and future perspectives.
Mol Cancer. 15:392016. View Article : Google Scholar : PubMed/NCBI
|
|
91
|
Xie H, Ma H and Zhou D: Plasma HULC as a
promising novel biomarker for the detection of hepatocellular
carcinoma. Biomed Res Int. 2013:1361062013. View Article : Google Scholar : PubMed/NCBI
|
|
92
|
Revenfeld AL, Bæk R, Nielsen MH,
Stensballe A, Varming K and Jørgensen M: Diagnostic and prognostic
potential of extracellular vesicles in peripheral blood. Clin Ther.
36:830–846. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
93
|
Mathieu M, Martin-Jaular L, Lavieu G and
Théry C: Specificities of secretion and uptake of exosomes and
other extracellular vesicles for cell-to-cell communication. Nat
Cell Biol. 21:9–17. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
94
|
Benes V and Castoldi M: Expression
profiling of microRNA using real-time quantitative PCR, how to use
it and what is available. Methods. 50:244–249. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
95
|
Hu HB, Jie HY and Zheng XX: Three
circulating LncRNA predict early progress of esophageal squamous
cell carcinoma. Cell Physiol Biochem. 40:117–125. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
96
|
Hu L, Xie K, Zheng C, Qiu B, Jiang Z, Luo
C, Diao Y, Luo J, Yao X and Shen Y: Exosomal MALAT1 promotes the
proliferation of esophageal squamous cell carcinoma through
glyoxalase 1-dependent methylglyoxal removal. Noncoding RNA Res.
9:330–340. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
97
|
Rong H, Chen B, Ma K, Wei X, Peng J and
Zhu J: Downregulation of lncRNA LINC-PINT participates in the
recurrence of esophageal squamous cell carcinoma possibly by
interacting miRNA-21. Cancer Biother Radiopharm. 36:273–279.
2021.PubMed/NCBI
|
|
98
|
Sharma U, Barwal TS, Khandelwal A, Rana
MK, Rana APS, Singh K and Jain A: Circulating long Non-Coding RNAs
LINC00324 and LOC100507053 as potential liquid biopsy markers for
esophageal squamous cell carcinoma: A pilot study. Front Oncol.
12:8239532022. View Article : Google Scholar : PubMed/NCBI
|
|
99
|
Uttam V, Rana MK, Sharma U, Singh K and
Jain A: Circulating long non-coding RNA EWSAT1 acts as a liquid
biopsy marker for esophageal squamous cell carcinoma: A pilot
study. Noncoding RNA Res. 9:1–11. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
100
|
Zhang J, Hu SL, Qiao CH, Ye JF, Li M, Ma
HM, Wang JH, Xin SY and Yuan ZL: LncRNA-NEF inhibits proliferation,
migration and invasion of esophageal squamous-cell carcinoma cells
by inactivating wnt/β-catenin pathway. Eur Rev Med Pharmacol Sci.
22:6824–6831. 2018.PubMed/NCBI
|
|
101
|
Jiao Z, Yu A, Rong W, He X, Zen K, Shi M
and Wang T: Five-lncRNA signature in plasma exosomes serves as
diagnostic biomarker for esophageal squamous cell carcinoma. Aging
(Albany NY). 12:15002–15010. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
102
|
Yan S, Du L, Jiang X, Duan W, Li J, Xie Y,
Zhan Y, Zhang S, Wang L, Li S and Wang C: Evaluation of serum
exosomal lncRNAs as diagnostic and prognostic biomarkers for
esophageal squamous cell carcinoma. Cancer Manag Res. 12:9753–9763.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
103
|
Yao W, Liu J, Hou Z, Jia X, Yang D, Feng
M, Wu S and Wei L: Recombinant human protein TCFL5-activated
NRSN2-AS1 promotes esophageal cancer progression via the
microRNA-874-5p/RELT regulatory axis. Int J Biol Macromol.
277:1338142024. View Article : Google Scholar : PubMed/NCBI
|
|
104
|
Luo Q, Kuang Y, Tao X, Zhu X, Zhao X, Lu
G, Zhang W, Sun E and Chen B: Pan-cancer analysis of PCAT6 and its
effect on oesophageal squamous cell carcinoma cell proliferation
and migration. Med Oncol. 40:1252023. View Article : Google Scholar : PubMed/NCBI
|
|
105
|
Huang T, You Q, Huang D, Zhang Y, He Z,
Shen X, Li F, Shen Q, Onyebuchi IC, Wu C, et al: A positive
feedback between PDIA3P1 and OCT4 promotes the cancer stem cell
properties of esophageal squamous cell carcinoma. Cell Commun
Signal. 22:602024. View Article : Google Scholar : PubMed/NCBI
|
|
106
|
Zhang S, Jiang H, Xu Z, Jiang Y, She Y,
Huang X, Feng S, Chen W, Chen S, Chen Y, et al: The resistance of
esophageal cancer cells to paclitaxel can be reduced by the
knockdown of long noncoding RNA DDX11-AS1 through TAF1/TOP2A
inhibition. Am J Cancer Res. 9:2233–2248. 2019.PubMed/NCBI
|
|
107
|
Liu H, Zhang J, Luo X, Zeng M and Xu L,
Zhang Q, Liu H, Guo J and Xu L: Overexpression of the long
noncoding RNA FOXD2-AS1 promotes cisplatin resistance in esophageal
squamous cell carcinoma through the miR-195/Akt/mTOR axis. Oncol
Res. 28:65–73. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
108
|
Shen GY, Zhang Y, Huang RZ, Huang ZY, Yang
LY, Chen DZ and Yang SB: FOXP4-AS1 promotes CD8+ T cell exhaustion
and esophageal cancer immune escape through USP10-stabilized PD-L1.
Immunol Res. 72:766–775. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
109
|
Guo Y, Wang L, Yang H and Ding N:
Knockdown long non-coding RNA HCP5 enhances the radiosensitivity of
esophageal carcinoma by modulating AKT signaling activation.
Bioengineered. 13:884–893. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
110
|
Lin K, Jiang H, Zhuang SS, Qin YS, Qiu GD,
She YQ, Zheng JT, Chen C, Fang L and Zhang SY: Long noncoding RNA
LINC00261 induces chemosensitization to 5-fluorouracil by mediating
methylation-dependent repression of DPYD in human esophageal
cancer. FASEB J. 33:1972–1988. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
111
|
Sun Y, Wang J, Pan S, Yang T, Sun X, Wang
Y, Shi X, Zhao X, Guo J and Zhang X: LINC00657 played oncogenic
roles in esophageal squamous cell carcinoma by targeting miR-615-3p
and JunB. Biomed Pharmacother. 108:316–324. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
112
|
Liang F, Luo Q, Han H, Zhang J, Yang Y and
Chen J: Long noncoding RNA LINC01088 inhibits esophageal squamous
cell carcinoma progression by targeting the NPM1-HDM2-p53 axis.
Acta Biochim Biophys Sin (Shanghai). 55:367–381. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
113
|
Wu K, Wang Z, Huang Y, Yao L, Kang N, Ge
W, Zhang R and He W: LncRNA PTPRG-AS1 facilitates glycolysis and
stemness properties of esophageal squamous cell carcinoma cells
through miR-599/PDK1 axis. J Gastroenterol Hepatol. 37:507–517.
2022. View Article : Google Scholar : PubMed/NCBI
|
|
114
|
Tan R, Liu J, Wang J, Zhang W, He M and
Zhang Y: Long noncoding RNA SNHG6 silencing sensitized esophageal
cancer cells to 5-FU via EZH2/STAT pathway. Sci Rep. 13:53632023.
View Article : Google Scholar : PubMed/NCBI
|
|
115
|
Wang P, Yang Z, Ye T, Shao F, Li J, Sun N
and He J: lncTUG1/miR-144-3p affect the radiosensitivity of
esophageal squamous cell carcinoma by competitively regulating
c-MET. J Exp Clin Cancer Res. 39:72020. View Article : Google Scholar : PubMed/NCBI
|
|
116
|
Shi W, Gao Z, Song J and Wang W: Silence
of FOXD2-AS1 inhibited the proliferation and invasion of esophagus
cells by regulating miR-145-5p/CDK6 axis. Histol Histopathol.
35:1013–1021. 2020.PubMed/NCBI
|
|
117
|
Xu J, Ma J, Guan B, Li J, Wang Y and Hu S:
LncRNA HCP5 promotes malignant cell behaviors in esophageal
squamous cell carcinoma via the PI3K/AKT/mTOR signaling. Cell
Cycle. 20:1374–1388. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
118
|
Xu J, Liu X, Liu X and Zhi Y: Long
noncoding RNA KCNMB2-AS1 promotes the development of esophageal
cancer by modulating the miR-3194-3p/PYGL axis. Bioengineered.
12:6687–6702. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
119
|
Zhang F, Fan L, Kang X, Wei H and Li L:
High LINC00626 expression promotes esophagogastric junction
adenocarcinoma metastasis: The mediating role of the
JAK1/STAT3/KHSRP axis. Nan Fang Yi Ke Da Xue Xue Bao. 44:541–552.
2024.PubMed/NCBI
|
|
120
|
Zhang W, Chen Q and Lei C: lncRNA MIAT
promotes cell invasion and migration in esophageal cancer. Exp Ther
Med. 19:3267–3274. 2020.PubMed/NCBI
|
|
121
|
Chu J, Li H, Xing Y, Jia J, Sheng J, Yang
L, Sun K, Qu Y, Zhang Y, Yin H, et al: LncRNA MNX1-AS1 promotes
progression of esophageal squamous cell carcinoma by regulating
miR-34a/SIRT1 axis. Biomed Pharmacother. 116:1090292019. View Article : Google Scholar : PubMed/NCBI
|
|
122
|
Li Y, Li J, Luo M, Zhou C, Shi X, Yang W,
Lu Z, Chen Z, Sun N and He J: Novel long noncoding RNA NMR promotes
tumor progression via NSUN2 and BPTF in esophageal squamous cell
carcinoma. Cancer Lett. 430:57–66. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
123
|
Zhang S, Liao W, Wu Q, Huang X, Pan Z,
Chen W, Gu S, Huang Z, Wang Y, Tang X, et al: LINC00152 upregulates
ZEB1 expression and enhances epithelial-mesenchymal transition and
oxaliplatin resistance in esophageal cancer by interacting with
EZH2. Cancer Cell Int. 20:5692020. View Article : Google Scholar : PubMed/NCBI
|
|
124
|
Niu G, Zhuang H, Li B and Cao G: Long
noncoding RNA linc-UBC1 promotes tumor invasion and metastasis by
regulating EZH2 and repressing E-cadherin in esophageal squamous
cell carcinoma. J BUON. 23:157–162. 2018.PubMed/NCBI
|
|
125
|
Li MK, Liu LX, Zhang WY, Zhan HL, Chen RP,
Feng JL and Wu LF: Long non-coding RNA MEG3 suppresses
epithelial-to-mesenchymal transition by inhibiting the
PSAT1-dependent GSK-3β/Snail signaling pathway in esophageal
squamous cell carcinoma. Oncol Rep. 44:2130–2142. 2020.PubMed/NCBI
|
|
126
|
Guo B, He M, Ma M, Tian Z, Jin J and Tian
G: Long Non-coding RNA X-inactive specific transcript promotes
esophageal squamous cell carcinoma progression via the MicroRNA
34a/Zinc finger E-box-Binding homeobox 1 pathway. Dig Dis Sci.
69:1169–1181. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
127
|
Xiao Y, Tang J, Yang D, Zhang B, Wu J, Wu
Z, Liao Q, Wang H, Wang W and Su M: Long noncoding RNA LIPH-4
promotes esophageal squamous cell carcinoma progression by
regulating the miR-216b/IGF2BP2 axis. Biomark Res. 10:602022.
View Article : Google Scholar : PubMed/NCBI
|
|
128
|
Li D, Li D, Meng L, Liu J, Huang C and Sun
H: LncRNA NLIPMT inhibits tumorigenesis in esophageal Squamous-cell
carcinomas by regulating miR-320/Survivin axis. Cancer Manag Res.
12:12603–12612. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
129
|
Zhang Y, Li R, Ding X, He M and Zhang R:
Long noncoding RNA SNHG6 promotes oesophageal squamous cell
carcinoma by downregulating the miR-101-3p/EZH2 pathway. J Biochem
Mol Toxicol. 36:e229592022. View Article : Google Scholar : PubMed/NCBI
|
|
130
|
Hu D, Ma A, Lu H, Gao Z, Yu Y, Fan J, Liu
S, Wang Y and Zhang M: LINC00963 promotes cisplatin resistance in
esophageal squamous cell carcinoma by interacting with miR-10a to
Upregulate SKA1 expression. Appl Biochem Biotechnol. 196:7219–7232.
2024. View Article : Google Scholar : PubMed/NCBI
|
|
131
|
Zhao F, Tian H, Wang Y, Zhang J, Liu F and
Fu L: LINC01004-SPI1 axis-activated SIGLEC9 in tumor-associated
macrophages induces radioresistance and the formation of
immunosuppressive tumor microenvironment in esophageal squamous
cell carcinoma. Cancer Immunol Immunother. 72:1835–1851. 2023.
View Article : Google Scholar : PubMed/NCBI
|
|
132
|
Liu G, Guo W, Chen G, Li W, Cui Y, Qin J
and Peng J: Lnc-MCEI mediated the chemosensitivity of esophageal
squamous cell carcinoma via miR-6759-5p to competitively regulate
IGF2. Int J Biol Sci. 16:2938–2950. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
133
|
Zhu ZJ, Pang Y, Jin G, Zhang HY, Wang WH,
Liu JW, Tuo GX, Wu P, Yang Y, Wang ZQ and Wang K: Hypoxia induces
chemoresistance of esophageal cancer cells to cisplatin through
regulating the lncRNA-EMS/miR-758-3p/WTAP axis. Aging (Albany NY).
13:17155–17176. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
134
|
Xu C, Guo Y, Liu H, Chen G, Yan Y and Liu
T: TUG1 confers cisplatin resistance in esophageal squamous cell
carcinoma by epigenetically suppressing PDCD4 expression via EZH2.
Cell Biosci. 8:612018. View Article : Google Scholar : PubMed/NCBI
|
|
135
|
Zhang H, Hua Y, Jiang Z, Yue J, Shi M,
Zhen X, Zhang X, Yang L, Zhou R and Wu S: Cancer-associated
Fibroblast-promoted LncRNA DNM3OS confers radioresistance by
regulating DNA damage response in esophageal squamous cell
carcinoma. Clin Cancer Res. 25:1989–2000. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
136
|
Wu J, Liu Y, Huang X, Cheng Y, Qian Z, Ni
X, Chen S, Lin M and Luo J: LncRNA DGCR5 silencing enhances the
Radio-sensitivity of human esophageal squamous cell carcinoma via
negatively regulating the Warburg effect. Radiat Res. 199:264–272.
2023. View Article : Google Scholar : PubMed/NCBI
|
|
137
|
Chen M, Liu P, Chen Y, Chen Z, Shen M, Liu
X, Li X, Li A, Lin Y, Yang R, et al: Long noncoding RNA FAM201A
mediates the radiosensitivity of esophageal squamous cell cancer by
regulating ATM and mTOR expression via miR-101. Front Genet.
9:6112018. View Article : Google Scholar : PubMed/NCBI
|
|
138
|
Lin J, Liu Z, Liao S, Li E, Wu X and Zeng
W: Elevation of long non-coding RNA GAS5 and knockdown of
microRNA-21 up-regulate RECK expression to enhance esophageal
squamous cell carcinoma cell radio-sensitivity after radiotherapy.
Genomics. 112:2173–2185. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
139
|
Hu M, Zhang Q, Tian XH, Wang JL, Niu YX
and Li G: lncRNA CCAT1 is a biomarker for the proliferation and
drug resistance of esophageal cancer via the miR-143/PLK1/BUBR1
axis. Mol Carcinog. 58:2207–2217. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
140
|
Nan Y, Luo Q, Wu X, Chang W, Zhao P, Liu S
and Liu Z: HCP5 prevents ubiquitination-mediated UTP3 degradation
to inhibit apoptosis by activating c-Myc transcriptional activity.
Mol Ther. 31:552–568. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
141
|
Chen W, Zhang Y, Wang H, Pan T, Zhang Y
and Li C: LINC00473/miR-374a-5p regulates esophageal squamous cell
carcinoma via targeting SPIN1 to weaken the effect of radiotherapy.
J Cell Biochem. 120:14562–14572. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
142
|
Liu WH, Qiao HY, Xu J, Wang WQ, Wu YL and
Wu X: LINC00473 contributes to the radioresistance of esophageal
squamous cell carcinoma by regulating microRNA-497-5p and cell
division cycle 25A. Int J Mol Med. 46:571–582. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
143
|
Wang L, Wang X, Yan P, Liu Y and Jiang X:
LINC00261 suppresses cisplatin resistance of esophageal squamous
cell carcinoma through miR-545-3p/MT1M Axis. Front Cell Dev Biol.
9:6877882021. View Article : Google Scholar : PubMed/NCBI
|
|
144
|
Li N, Zhao Z, Miao F, Cai S, Liu P, Yu Y
and Wang B: Silencing of long non-coding RNA LINC01270 inhibits
esophageal cancer progression and enhances chemosensitivity to
5-fluorouracil by mediating GSTP1methylation. Cancer Gene Ther.
28:471–485. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
145
|
Jia Y, Tian C, Wang H, Yu F, Lv W, Duan Y,
Cheng Z, Wang X, Wang Y, Liu T, et al: Long non-coding RNA
NORAD/miR-224-3p/MTDH axis contributes to CDDP resistance of
esophageal squamous cell carcinoma by promoting nuclear
accumulation of β-catenin. Mol Cancer. 20:1622021. View Article : Google Scholar : PubMed/NCBI
|
|
146
|
Sun Y, Wang J, Ma Y, Li J, Sun X, Zhao X,
Shi X, Hu Y, Qu F and Zhang X: Radiation induces NORAD expression
to promote ESCC radiotherapy resistance via EEPD1/ATR/Chk1
signalling and by inhibiting pri-miR-199a1 processing and the
exosomal transfer of miR-199a-5p. J Exp Clin Cancer Res.
40:3062021. View Article : Google Scholar : PubMed/NCBI
|
|
147
|
Chen Z, Wang Q, Huang L, Xu G and Hu J:
LncRNA PVT1 confers cisplatin resistance of esophageal cancer cells
through modulating the miR-181a-5p-glutaminase (GLS) axis. Nutr
Cancer. 75:1646–1657. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
148
|
Wang L, Yu X, Zhang Z, Pang L, Xu J, Jiang
J, Liang W, Chai Y, Hou J and Li F: Linc-ROR promotes esophageal
squamous cell carcinoma progression through the derepression of
SOX9. J Exp Clin Cancer Res. 36:1822017. View Article : Google Scholar : PubMed/NCBI
|
|
149
|
Sahebi R, Malakootian M, Balalaee B,
Shahryari A, Khoshnia M, Abbaszadegan MR, Moradi A and Javad Mowla
S: Linc-ROR and its spliced variants 2 and 4 are significantly
up-regulated in esophageal squamous cell carcinoma. Iran J Basic
Med Sci. 19:1131–1135. 2016.PubMed/NCBI
|
|
150
|
Chen Y, Tang J, Li L and Lu T: Effect of
Linc-POU3F3 on radiotherapy resistance and cancer stem cell markers
of esophageal cancer cells. Zhong Nan Da Xue Xue Bao Yi Xue Ban.
46:583–590. 2021.(In English, Chinese). PubMed/NCBI
|
|
151
|
Shahryari A, Rafiee MR, Fouani Y, Oliae
NA, Samaei NM, Shafiee M, Semnani S, Vasei M and Mowla SJ: Two
novel splice variants of SOX2OT, SOX2OT-S1, and SOX2OT-S2 are
coupregulated with SOX2 and OCT4 in esophageal squamous cell
carcinoma. Stem Cells. 32:126–134. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
152
|
Xue ST, Cao SQ, Ding JC, Li WJ, Hu GS,
Zheng JC, Lin X, Chen C, Liu W and Zheng B: LncRNA LUESCC promotes
esophageal squamous cell carcinoma by targeting the
miR-6785-5p/NRSN2 axis. Cell Mol Life Sci. 81:1212024. View Article : Google Scholar : PubMed/NCBI
|
|
153
|
Wang Y, Wang Y, Zhang J, Shi Z and Liu J:
LncRNA NONHSAT227443.1 confers esophageal squamous cell carcinoma
chemotherapy resistance by activating PI3K/AKT signaling via
targeting MRTFB. Technol Cancer Res Treat.
23:153303382412743692024. View Article : Google Scholar : PubMed/NCBI
|
|
154
|
Li HM, Yu YK, Liu Q, Wei XF, Zhang J,
Zhang RX, Sun HB, Wang ZF, Xing WQ and Li Y: LncRNA SNHG1 regulates
the progression of esophageal squamous cell cancer by the
miR-204/HOXC8 axis. Onco Targets Ther. 13:757–767. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
155
|
Sun S, Huang C, Fan W, Wang Z, Li K, Liu
X, Wang Z, Zhao T, Zhang G and Li X: FAM136A as a diagnostic
biomarker in esophageal cancer: Insights into immune infiltration,
m6A modification, alternative splicing, cuproptosis, and the ceRNA
network. Adv Biol (Weinh). 8:e24001572024. View Article : Google Scholar : PubMed/NCBI
|
|
156
|
Yang B, Ma H and Bian Y: LINC00261
inhibits esophageal cancer radioresistance by Down-regulating
microRNA-552-3p and promoting DIRAS1. Cancer Manag Res.
13:8559–8573. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
157
|
Yang C, Shen S, Zheng X, Ye K, Ge H, Sun Y
and Lu Y: Long non-coding RNA LINC00337 induces autophagy and
chemoresistance to cisplatin in esophageal squamous cell carcinoma
cells via upregulation of TPX2 by recruiting E2F4. FASEB J.
34:6055–6069. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
158
|
Kong N, Chi Y, Ma H and Luo D: LncRNA
SNHG1 acts as a ceRNA for miR-216a-3p to regulate TMBIM6 expression
in esophageal squamous cell carcinoma. J Cancer. 15:3128–3139.
2024. View Article : Google Scholar : PubMed/NCBI
|
|
159
|
Li Z, Yan H, Wang B, Wang H, Chen A, Zhu
T, Liu J, Yu G and Kang M: High methylation of the same promoter of
lncRNA ZNF582-AS1/ZNF582 promotes malignant progression of
esophageal cancer. Epigenomics. 16:733–752. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
160
|
Sharma A, Boise LH and Shanmugam M: Cancer
metabolism and the evasion of apoptotic cell death. Cancers
(Basel). 11:11442019. View Article : Google Scholar : PubMed/NCBI
|
|
161
|
Neve B, Jonckheere N, Vincent A and Van
Seuningen I: Epigenetic regulation by lncRNAs: An overview focused
on UCA1 in colorectal cancer. Cancers (Basel). 10:4402018.
View Article : Google Scholar : PubMed/NCBI
|
|
162
|
Lou W, Ding B and Fu P: Pseudogene-derived
lncRNAs and their miRNA sponging mechanism in human cancer. Front
Cell Dev Biol. 8:852020. View Article : Google Scholar : PubMed/NCBI
|
|
163
|
Statello L, Guo CJ, Chen LL and Huarte M:
Gene regulation by long non-coding RNAs and its biological
functions. Nat Rev Mol Cell Biol. 22:96–118. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
164
|
Nasrolahi A, Khojasteh Pour F, Mousavi
Salehi A, Kempisty B, Hajizadeh M, Feghhi M, Azizidoost S and
Farzaneh M: Potential roles of lncRNA MALAT1-miRNA interactions in
ocular diseases. J Cell Commun Signal. 17:1203–1217. 2023.
View Article : Google Scholar : PubMed/NCBI
|
|
165
|
Sarropoulos I, Marin R, Cardoso-Moreira M
and Kaessmann H: Developmental dynamics of lncRNAs across mammalian
organs and species. Nature. 571:510–514. 2019. View Article : Google Scholar : PubMed/NCBI
|
